Serum Kisspeptin: a Predictive Marker of Miscarriage or Not?
A Prospective Study to Evaluate Whether Serum Kisspeptin is a Marker Predictive of the First Trimester Miscarriage of Women Who Conceive in IVF
Sponsor: ShangHai Ji Ai Genetics & IVF Institute
A observational or N/A phase clinical study on Miscarriage, this trial is completed. The trial is conducted by ShangHai Ji Ai Genetics & IVF Institute and has accumulated 9 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Apr 2021 — Dec 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Jul 2020 — Nov 2020 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Aug 2019 — Jul 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jun 2019 — Aug 2019 [monthly]
Not Yet Recruiting
First recorded
May 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- ShangHai Ji Ai Genetics & IVF Institute
For direct contact, visit the study record on ClinicalTrials.gov .